Bio-Techne
TECH
#1486
Rank
C$16.70 B
Marketcap
$105.13
Share price
2.49%
Change (1 day)
3.75%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.11

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.26. In 2022 the company made an earnings per share (EPS) of $2.40 an increase over its 2021 EPS that were of $1.93.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-12.04%
2022$2.4024.35%
2021$1.9317.98%
2020$1.64-10.94%
2019$1.84101.57%
2018$0.91-17.53%
2017$1.1139.37%
2016$0.79-17.23%
2015$0.96-14.97%
2014$1.131.29%
2013$1.113.68%
2012$1.07-1.97%
2011$1.101.67%
2010$1.087.14%
2009$1.01-1.06%
2008$1.0219.41%
2007$0.8519.1%
2006$0.7110.56%
2005$0.6529.5%
2004$0.5013.05%
2003$0.4468.43%
2002$0.26-17.05%
2001$0.3217.33%
2000$0.2748.51%
1999$0.1823.17%
1998$0.1513.89%
1997$0.1342.57%
1996$0.09070

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.04 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.22-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.97 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.52 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.09-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$12.28 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.35-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA